US 10710983
2,4-diamino-pyrimidine compounds and method for making and using the compounds
granted A61PA61P11/06A61P13/00
Quick answer
US patent 10710983 (2,4-diamino-pyrimidine compounds and method for making and using the compounds) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P11/06, A61P13/00, A61P25/00, A61P29/00